Thank you
This live web event has ended. Thank you for attending.
This live web event has ended. Thank you for attending.
Dr. Guzman is an Associate Professor of Pharmacology in
Medicine, appointed in the Division of Hematology & Medical Oncology in the
Department of Medicine. She was recruited to Weill Cornell Medical College in
2009 from the University of Rochester. As the first scientist to identify
dysregulated gene networks in leukemia stem cells and capitalize on this
dysregulation to develop therapies to destroy them, she is widely viewed as one
of the world's foremost experts in therapeutic targeting of leukemia stem
cells. Her postdoctoral training was completed in the laboratory of Dr. Craig
T. Jordan, a recognized leader in therapeutic targeting of leukemia stem cells.
Before joining Weill Cornell, Dr. Guzman was appointed as an Instructor of
Medicine at the University of Rochester. She has authored or co-authored
numerous papers, book chapters, and review articles in journals such as the
Proceedings of the National Academy of Sciences, Blood, and the New England
Journal of Medicine.
As an independent investigator, Dr. Guzman has received funding
from the NIH, Leukemia & Lymphoma Society, V Foundation, and other
organizations. Her passion is to perform world class translational research
through close interactions between research and clinic to accelerate the
development of new and more effective leukemia treatments that ablate leukemia
stem cells.